Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy
about
Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and managementBalancing antiplatelet and anticoagulant therapies in patients with cardiovascular disease.Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients.What do you do with the antiplatelet agents in patients with drug eluting stents who then receive a mechanical valve?The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions.Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literatureAspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observationalUpper Digestive Bleeding in Atrial Fibrillation: Evaluation of Gastroscopy Prior to Oral Anticoagulant Therapy (GOAT), Prospective, Randomized, Double Blind Study on a Community Population.Targeting therapy to the fibrin-mediated pathophysiology of acute coronary syndrome.Adverse drug events as a cause of hospitalization in older adults.Factors predictive for a positive invasive mesenteric angiogram following a positive CT angiogram in patients with acute lower gastrointestinal haemorrhage.The safety and efficacy of mesenteric embolization in the management of acute lower gastrointestinal hemorrhage.Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis.Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.Predictors and prognosis of left ventricular thrombus in post-myocardial infarction patients with left ventricular dysfunction after percutaneous coronary intervention
P2860
Q33750028-8AE0B64B-45F5-4DFC-A045-3CEDD25423E6Q33936118-3A70CE82-C8D9-4E26-AAEE-5E6DB0249AFEQ34415964-38C1A9BA-2165-4857-ABDE-30972231720DQ34793416-800F6A34-9AE3-4964-A298-E887770874D8Q35627390-4D157096-4E22-42DB-A652-EBD01D0C376BQ36051860-D88C0148-11AE-4366-9EAF-047833FB4987Q36077326-BEF86E45-85C8-4E2F-9CCE-E708CD2D7D27Q36411732-EF0D3381-6B05-46BD-A9AE-58BA5D4672B9Q36512498-7E448EB4-061F-4F14-9922-359E77D2337BQ37162895-88CD8961-6E26-4AE0-ADCA-E812D4A691C1Q37608355-A56EE3FF-86B3-4648-9B3D-66C954E70230Q37711335-8F4C18CE-694F-42FA-A14C-58AC1CD04952Q38076348-E5AFBEF3-D9B6-4C30-9F78-F3BBA5F0C694Q38085222-C9B7F960-9753-4B97-BAB4-E0DD0A7A154DQ38120194-B9660C71-86B0-47E5-B225-0C887C9F1BE2Q38166384-F121B12C-E9C7-403F-89A4-380FE2EFA3ECQ38541932-48B4117D-998B-4FE3-8166-CA0A7B051710Q42180636-22C104C1-880F-4B04-8C60-8978CBB0E095Q46001195-9C89E533-458A-49C7-A4D0-80291B2D151FQ46636618-C97C761B-9584-4C4B-9930-4E21D76D27E4Q57172937-476B9EB9-FD5E-4ACE-9526-1A5FD4DD9DC4
P2860
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Risk of major bleeding with co ...... ing long-term warfarin therapy
@ast
Risk of major bleeding with co ...... ing long-term warfarin therapy
@en
Risk of major bleeding with co ...... ing long-term warfarin therapy
@nl
type
label
Risk of major bleeding with co ...... ing long-term warfarin therapy
@ast
Risk of major bleeding with co ...... ing long-term warfarin therapy
@en
Risk of major bleeding with co ...... ing long-term warfarin therapy
@nl
prefLabel
Risk of major bleeding with co ...... ing long-term warfarin therapy
@ast
Risk of major bleeding with co ...... ing long-term warfarin therapy
@en
Risk of major bleeding with co ...... ing long-term warfarin therapy
@nl
P2093
P2860
P356
P1433
P1476
Risk of major bleeding with co ...... ing long-term warfarin therapy
@en
P2093
Arnold Greenspon
Christopher McGowan
Deborah DeEugenio
Inna Chervoneva
Jocelyn Andrel
Louis Kolman
Mark DeCaro
Matthew DeCaro
P2860
P356
10.1592/PHCO.27.5.691
P407
P577
2007-05-01T00:00:00Z